Evidence map›Paper›PMID 33434736›Full record

ArticleSchizophrenia research2021

Abnormalities in the copper transporter CTR1 in postmortem hippocampus in schizophrenia: A subregion and laminar analysis.

Kirsten E Schoonover, Charlene B Farmer, Charity J Morgan, Vidushi Sinha, Laura Odom, Rosalinda C Roberts

Open access · greenAbstract read
In one paragraph

Article in Schizophrenia research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. A primer on copper biology in the brain.Neurobiology of disease · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genetic polymorphism and neuroanatomical changes in schizophrenia.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kirsten E SchoonoverDepartment of Psychology and Behavioral Neuroscience, University of Alabama at Birmingham, United States of America. Electronic address: schoonoverke@upmc.edu.
Charlene B FarmerDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, United States of America.
Charity J MorganDepartment of Biostatistics, University of Alabama at Birmingham, United States of America.
Vidushi SinhaDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, United States of America.
Laura OdomDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, United States of America.
Rosalinda C RobertsDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, United States of America. Electronic address: rosalindaroberts@uabmc.edu.
University of Alabama at Birmingham · US

Funding

White matter pathology in postmortem schizophrenia brainR21MH108867 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROBERTS, ROSALINDA C · 2016 to 2017
$404k
Pyramidal neuron hypoactivity in schizophrenia cortexK00MH122943 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SCHOONOVER, KIRSTEN · 2019 to 2022
$339k
Mechanisms of Dysbindin Abnormalities in SchizophreniaF99NS105208 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SCHOONOVER, KIRSTEN · 2017 to 2018
$71k
NIMH NIH HHS K00 MH122943NIMH NIH HHS R21 MH108867NINDS NIH HHS F99 NS105208
6 · The paper itself

Abstract

Dysbindin-1 modulates copper transport, which is crucial for cellular homeostasis. Several brain regions implicated in schizophrenia exhibit decreased levels of dysbindin-1, which may affect copper homeostasis therein. Our recent study showed decreased levels of dysbindin-1, the copper transporter-1 (CTR1) and copper in the substantia nigra in schizophrenia, providing the first evidence of disrupted copper transport in schizophrenia. In the present study, we hypothesized that there would be lower levels of dysbindin-1 and CTR1 in the hippocampus in schizophrenia versus a comparison group. Using semi-quantitative immunohistochemistry for dysbindin1 and CTR1, we measured the optical density in a layer specific fashion in the hippocampus and entorhinal cortex in ten subjects with schizophrenia and ten comparison subjects. Both regions were richly immunolabeled for CTR1 and dysbindin1 in both groups. In the superficial layers of the entorhinal cortex, CTR1 immunolabeled neuropil and cells showed lower optical density values in patients versus the comparison group. In the molecular layer of the dentate gyrus, patients had higher optical density values of CTR1 versus the comparison group. The density and distribution of dysbindin-1 immunolabeling was similar between groups. These laminar specific alterations of CTR1 in schizophrenia suggest abnormal copper transport in those locations.

Indexed as

SchizophreniaAutopsyBrainCopper Transporter 1DysbindinHippocampusHumansCopper Transporter 1DTNBP1 protein, humanDysbindinSLC31A1 protein, humanCopperDTNBP1 geneDysbindinEntorhinal cortexImmunohistochemistry

Identifiers

PMID33434736
PMCPMC7987889
OpenAlexW3120574409

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.